HealthStream Future Growth
Future criteria checks 1/6
HealthStream is forecast to grow earnings and revenue by 10.5% and 4.9% per annum respectively while EPS is expected to grow by 10.7% per annum.
Key information
10.5%
Earnings growth rate
10.68%
EPS growth rate
| Healthcare Services earnings growth | 22.3% |
| Revenue growth rate | 4.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 May 2026 |
Recent future growth updates
Analysis Article • Nov 06
Earnings Beat: HealthStream, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...Analysis Article • Feb 27
HealthStream, Inc. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next
Shareholders might have noticed that HealthStream, Inc. ( NASDAQ:HSTM ) filed its yearly result this time last week...Recent updates
Narrative Update • Apr 22
HSTM: AI Disruption Risks And Capital Returns Will Drive Future Share Performance
Narrative Update on HealthStream Analysts have reset their price target on HealthStream to $21 from $25, citing respectable 4Q'25 results and management's detailed response to AI-related risks. They view this as leaving the company relatively better positioned than many other SaaS peers.
Narrative Update • Apr 08
HSTM: AI Risk Positioning And Capital Returns Will Support Upside Potential
Analysts have reduced the fair value estimate for HealthStream from $34.00 to $30.50, citing a lower forward P/E assumption and an increased discount rate, while also referencing recent Street research that trimmed the price target to $21 and highlighted both respectable 4Q'25 results and management's case that the company is relatively well positioned against AI-related risks in SaaS. Analyst Commentary Recent Street commentary on HealthStream focuses on how the company is handling AI related risks in SaaS and what that could mean for valuation and execution.Narrative Update • Mar 25
HSTM: AI Disruption Risks And Capital Returns Will Shape Future Outlook
Analysts have reset their price target on HealthStream to $21, down from $25, after incorporating fresh views on AI-related risks and management's argument that the company is relatively well positioned compared with other SaaS names. Analyst Commentary Bearish analysts have trimmed expectations on HealthStream by cutting the price target to $21 from $25, while maintaining a neutral stance on the shares.Narrative Update • Mar 10
HSTM: AI Risks, Capital Returns And Fair Value Will Shape Outlook
Analysts have reduced their price target on HealthStream to $21 from $25, citing a recalibration of fair value, discount rate and future P/E assumptions, while also highlighting management's view that the business model remains relatively well positioned against rising AI related concerns for SaaS names. Analyst Commentary Bearish analysts are signaling a more cautious stance on HealthStream after the latest quarterly update.Narrative Update • Feb 24
HSTM: Dividend Hike And Buyback Will Support Future Upside Potential
Analysts have kept their $25.00 price target for HealthStream unchanged, citing only slight tweaks to assumptions around the discount rate, revenue growth, profit margin, and future P/E that together do not materially shift their overall view on the stock. What's in the News The board approved a quarterly cash dividend of US$0.035 per share, a 12.9% increase from the prior US$0.031, payable on March 20, 2026, to shareholders of record on March 9, 2026 (company announcement).Narrative Update • Feb 10
HSTM: Fine Tuned Assumptions Will Support Future Upside Potential
Analysts kept their fair value estimate for HealthStream at $25.00, with modest tweaks to inputs such as discount rate, revenue growth, profit margin, and future P/E assumptions. This underpins the unchanged price target and reflects only fine tuning in their models rather than a shift in overall view.Analysis Article • Feb 07
HealthStream, Inc. (NASDAQ:HSTM) Investors Are Less Pessimistic Than Expected
HealthStream, Inc.'s ( NASDAQ:HSTM ) price-to-earnings (or "P/E") ratio of 28.8x might make it look like a sell right...Narrative Update • Jan 27
HSTM: Share Repurchases And Acquisition Efforts Will Drive Future Upside
Analysts now place their fair value estimate for HealthStream at US$25.00. The updated target reflects small tweaks to discount rate, revenue growth, profit margin, and future P/E assumptions in their models.Narrative Update • Jan 12
HSTM: Share Buybacks And M&A Activity Will Support Future Upside
Analysts have trimmed their fair value estimate for HealthStream from US$28 to about US$25. They cite updated assumptions on discount rates, revenue growth, profit margins, and a lower future P/E multiple in their refreshed models.Analysis Article • Nov 06
Earnings Beat: HealthStream, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...Analysis Article • Oct 30
A Look At The Intrinsic Value Of HealthStream, Inc. (NASDAQ:HSTM)
Key Insights Using the 2 Stage Free Cash Flow to Equity, HealthStream fair value estimate is US$29.23 With US$24.60...Seeking Alpha • Jun 04
HealthStream: High-Quality Business At A Fair Price
Summary HealthStream boasts a resilient, founder-led SaaS business model with decades of profitable growth, strong balance sheet, and shareholder-friendly capital returns. Revenue is highly recurring and predictable due to long-term, non-cancelable contracts, with built-in price escalators and industry-leading products recognized by G2. Short-term headwinds include funding cuts, customer bankruptcy, and delayed revenue recognition, prompting a downward revision in 2025 guidance, but technical issues are seen as temporary. Transition to SaaS and platform offerings positions HealthStream for higher margins and future growth, with most products tied to essential, mandatory healthcare requirements. Despite strong fundamentals, the stock remains expensive on a P/E basis but appears fairly valued on a P/S basis; thus, I rated it as HOLD overall, with a small starter position reflecting my long-term confidence in the business. Read the full article on Seeking AlphaAnalysis Article • May 23
We Discuss Why The CEO Of HealthStream, Inc. (NASDAQ:HSTM) Is Due For A Pay Rise
Key Insights HealthStream's Annual General Meeting to take place on 29th of May Total pay for CEO Bobby Frist includes...Analysis Article • May 07
HealthStream (NASDAQ:HSTM) Is Doing The Right Things To Multiply Its Share Price
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...Analysis Article • Feb 27
HealthStream, Inc. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next
Shareholders might have noticed that HealthStream, Inc. ( NASDAQ:HSTM ) filed its yearly result this time last week...Analysis Article • Nov 28
Should You Be Adding HealthStream (NASDAQ:HSTM) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Analysis Article • Nov 07
Returns At HealthStream (NASDAQ:HSTM) Are On The Way Up
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
New Narrative • Sep 24
Navigating Temporary Challenges, The Company Sets Its Sights On Long-term Revenue Growth And Market Expansion
Expansion into the health plan market and strong sales pipelines in key products signal potential for revenue growth and customer base diversification.Analysis Article • Aug 08
HealthStream, Inc.'s (NASDAQ:HSTM) Shareholders Might Be Looking For Exit
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...Analysis Article • Jul 17
We Ran A Stock Scan For Earnings Growth And HealthStream (NASDAQ:HSTM) Passed With Ease
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analysis Article • Apr 24
HealthStream, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2028 | 361 | N/A | 39 | N/A | 1 |
| 12/31/2027 | 343 | 24 | 42 | 84 | 5 |
| 12/31/2026 | 327 | 22 | 35 | 73 | 5 |
| 3/31/2026 | 312 | 20 | 33 | 63 | N/A |
| 12/31/2025 | 304 | 18 | 31 | 63 | N/A |
| 9/30/2025 | 299 | 21 | 29 | 61 | N/A |
| 6/30/2025 | 295 | 20 | 31 | 62 | N/A |
| 3/31/2025 | 292 | 19 | 35 | 64 | N/A |
| 12/31/2024 | 292 | 20 | 30 | 58 | N/A |
| 9/30/2024 | 288 | 20 | 32 | 60 | N/A |
| 6/30/2024 | 285 | 18 | 38 | 66 | N/A |
| 3/31/2024 | 283 | 18 | 37 | 64 | N/A |
| 12/31/2023 | 279 | 15 | 36 | 64 | N/A |
| 9/30/2023 | 277 | 13 | 31 | 58 | N/A |
| 6/30/2023 | 274 | 13 | 22 | 49 | N/A |
| 3/31/2023 | 270 | 12 | 24 | 51 | N/A |
| 12/31/2022 | 267 | 12 | 26 | 51 | N/A |
| 9/30/2022 | 263 | 9 | 24 | 49 | N/A |
| 6/30/2022 | 259 | 7 | 20 | 46 | N/A |
| 3/31/2022 | 259 | 6 | 19 | 44 | N/A |
| 12/31/2021 | 257 | 6 | 17 | 42 | N/A |
| 9/30/2021 | 254 | 7 | 18 | 42 | N/A |
| 6/30/2021 | 251 | 8 | 24 | 47 | N/A |
| 3/31/2021 | 247 | 9 | 28 | 49 | N/A |
| 12/31/2020 | 245 | 14 | 17 | 36 | N/A |
| 9/30/2020 | 246 | 17 | 26 | 44 | N/A |
| 6/30/2020 | 247 | 18 | 25 | 43 | N/A |
| 3/31/2020 | 250 | 17 | 30 | 56 | N/A |
| 12/31/2019 | 254 | 14 | N/A | 66 | N/A |
| 9/30/2019 | 251 | 14 | N/A | 67 | N/A |
| 6/30/2019 | 249 | 13 | N/A | 65 | N/A |
| 3/31/2019 | 242 | 14 | N/A | 51 | N/A |
| 12/31/2018 | 232 | 13 | N/A | 43 | N/A |
| 9/30/2018 | 227 | 13 | N/A | 40 | N/A |
| 6/30/2018 | 222 | 12 | N/A | 39 | N/A |
| 3/31/2018 | 218 | 11 | N/A | 39 | N/A |
| 12/31/2017 | 215 | 9 | N/A | 47 | N/A |
| 9/30/2017 | 218 | 5 | N/A | 45 | N/A |
| 6/30/2017 | 222 | 5 | N/A | 47 | N/A |
| 3/31/2017 | 224 | 4 | N/A | 35 | N/A |
| 12/31/2016 | 192 | 5 | N/A | 24 | N/A |
| 9/30/2016 | 223 | 6 | N/A | 24 | N/A |
| 6/30/2016 | 219 | 7 | N/A | 16 | N/A |
| 3/31/2016 | 216 | 7 | N/A | 32 | N/A |
| 12/31/2015 | 209 | 9 | N/A | 35 | N/A |
| 9/30/2015 | 198 | 9 | N/A | 31 | N/A |
| 6/30/2015 | 189 | 10 | N/A | 31 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HSTM's forecast earnings growth (10.5% per year) is above the savings rate (3.5%).
Earnings vs Market: HSTM's earnings (10.5% per year) are forecast to grow slower than the US market (16.8% per year).
High Growth Earnings: HSTM's earnings are forecast to grow, but not significantly.
Revenue vs Market: HSTM's revenue (4.9% per year) is forecast to grow slower than the US market (11.7% per year).
High Growth Revenue: HSTM's revenue (4.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HSTM's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/26 12:53 |
| End of Day Share Price | 2026/05/26 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
HealthStream, Inc. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Gillmor | Baird |
| Vincent Colicchio | Barrington Research Associates, Inc. |
| Richard Close | Canaccord Genuity |